Key result
Routine defibrillation threshold testing during ICD implantation provides no clinical benefit over standard programming without testing and should be reserved for select high-risk patients.
Why the study?
Does defibrillation threshold testing (DFT) improve outcomes in patients undergoing ICD implantation?
Population
Patients undergoing implantable cardioverter defibrillator implantation for primary or secondary prevention…
Comparison
Defibrillation threshold testing… vs No defibrillation threshold testing.
Design
Review
Authors
Loading...
May support omitting routine DFT testing at ICD implantation; leaves open prospective validation in high-risk subgroups.
Does defibrillation threshold testing (DFT) improve outcomes in patients undergoing ICD implantation?
Routine defibrillation threshold testing during ICD implantation does not improve clinical outcomes and should be reserved for select high-risk patients or those with complex anatomy.
Hayase et al. (2017) conducted a review in Implantable Cardioverter-Defibrillator (ICD) implantation. Defibrillation threshold testing (DFT) vs. No DFT testing was evaluated. Routine defibrillation threshold testing during ICD implantation provides no clinical benefit over standard programming without testing and should be reserved for select high-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: